Today’s discussion is with Monica Rutkowski Grippo, the founder and CEO of Rhea, a community supporting women through pregnancy loss & infertility (in beta). And our vision is bigger: a single, trusted resource for women's health needs. Monica nevers wants any woman to walk alone after pregnancy loss or infertility struggles so the Rhea community was born out of her own personal circumstances where the community she needed and wanted didn’t exist. So she’s creating it. At Rhea, their mission is to empower women to step into their reproductive power.

You can find Rhea Community @ https://www.linkedin.com/company/rheacommunity

Highlights from our discussion with Monica Grippo, founder of Rhea Community for women suffering trauma from infertility and pregnancy loss.

You can find Rhea Community @ https://www.linkedin.com/company/rheacommunity

This episode highlights the ongoing maternal health crisis in the U.S., a troubling reality for such a developed nation. It’s encouraging to see companies like Delfina tackling this issue, especially with a provider-first approach that supports clinicians under pressure. The return of doula support is also powerful—doulas truly can make a difference. For pregnant patients, Delfina offers peace of mind, access to vital information, and early insight into risks like pre-eclampsia.

Highlights from our conversation with Isabel "Izzy" Fulcher from Delfina.

Kiran Kumar is the CEO of Timeless Biotech, a reproductive longevity company that has prototyped the first-ever time-to-menopause predicting algorithm. And with this she’s created the MenoTime Predictor, an at home test kit that collects a simple blood sample that delivers you actionable results.

A seasoned digital marketer and biotechnology engineer from UC San Diego, Kiran brings a unique blend of scientific rigor and brand-building expertise to the longevity space. Her work sits at the intersection of biohacking, longevity, and machine learning, with a strong focus on translating cutting-edge biotech into consumer-facing solutions.

https://www.timelessbiotech.com/

Highlights from our conversation with Kiran Kumar from Timeless Biotech in episode 20.

Endometriosis is far more common than most probably realize, and the fact that it often goes undiagnosed for an average of 10 years is eye-opening. The severity of its symptoms makes it clear that better awareness and management tools are essential. With the rise of technology and AI, apps like Endo45 are meeting this need, allowing people to track symptoms and take a more active role in their healthcare. Just as there’s an app for everything, it makes sense to integrate this approach into condition management. By empowering patients with data, these tools enhance the quality and efficiency of time spent with doctors, ultimately improving care and outcomes.

Resources:

Check out Endo45 and download their app @ https://www.endo45.co.nz/

Highlights from our conversation with Juliet Oliver from Endo45 about ending endometriosis.